drugset
Drugs / Allogeneic Cardiosphere-Derived Cells (CDCs)
last change Apr 2020 re-read 3 minutes ago

Allogeneic Cardiosphere-Derived Cells (CDCs)

Cell therapy

Developed for
dilated cardiomyopathy · heart failure
Investigated by
Capricor Inc. · Cedars-Sinai Medical Center · National Heart, Lung, and Blood Institute (NHLBI) · National Institutes of Health (NIH)

Trials 1

today NCT02293603 · Ph 1
2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02293603 Nov 2014 → May 2015 dilated cardiomyopathy, heart failure Capricor Inc. Unknown Met primary

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Allogeneic Cardiosphere-Derived Cells (CDCs) ClinicalTrials.gov intervention name — accepted as the source's own label NCT02293603 ↗
Modality Cell therapy “Allogeneic Cardiosphere-Derived Cells (CDCs)” NCT02293603 ↗